FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101112 [Registered on: 14/01/2026] Trial Registered Prospectively
Last Modified On: 08/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Physiotherapy (Not Including YOGA)
Nutraceutical 
Study Design  Single Arm Study 
Public Title of Study   Effect of multicomponent rehabilitation on fall risk reduction in elderly patient hospitalized with parkinsonism and peripheral neuropathy 
Scientific Title of Study   Effect of multicomponent rehabilitation on fall risk reduction in elderly participant hospitalized with parkinsonism and peripheral neuropathy 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR ABHISHEK B SANNATANGIYAVAR 
Designation  POSTGRADUATE RESIDENT 
Affiliation  YENEPOYA MEDICAL COLLEGE AND HOSPITAL 
Address  GERIATRIC MEDICINE, 5TH FLOOR- F BLOCK, EMD BUILDING, YENEPOYA MEDICAL COLLEGE AND HOSPITAL, DERALAKATTE MANGALORE

Dakshina Kannada
KARNATAKA
575018
India 
Phone  9482553740  
Fax    
Email  abhisannatangi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Prabha Adhikari M.R. 
Designation  HEAD OF THE DEPARTMENT 
Affiliation  YENEPOYA MEDICAL COLLEGE AND HOSPITAL 
Address  GERIATRIC MEDICINE,5TH FLOOR- FWING, EMD BUILDING, YENEPOYA MEDICAL COLLEGE AND HOSPITAL, DERALAKATTE MANGALORE

Dakshina Kannada
KARNATAKA
575018
India 
Phone  9880991290  
Fax    
Email  prabha.raghuveer@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR ABHISHEK B SANNATANGIYAVAR 
Designation  POSTGRADUATE RESIDENT 
Affiliation  YENEPOYA MEDICAL COLLEGE AND HOSPITAL 
Address  GERIATRIC MEDICINE, 5TH FLOOR-F BLOCK, EMD BLOCK, YENEPOYA MEDICAL COLLEGE AND HOSPITAL, DERALAKATTE MANGALORE

Dakshina Kannada
KARNATAKA
575018
India 
Phone  8243506000  
Fax    
Email  geriatricmedicine@yenepoya.edu.in  
 
Source of Monetary or Material Support  
DR ABHISHEK B SANNATANGIYAVAR 
 
Primary Sponsor  
Name  DR ABHISHEK B SANNATANGIYAVAR 
Address  YENEPOYA MEDICAL COLLEGE AND HOSPITAL DERALAKATTE MANGALORE. 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR ABHISHEK B SANNATANGIYAVAR  YENEPOYA MEDICAL COLLEGE AND HOSPITAL  DEPARTMENT OF GERIATRIC MEDICINE, 5TH FLOOR- F BLOCK, EMD BUILDING.
Dakshina Kannada
KARNATAKA 
8243506000

geriatricmedicine@yenepoya.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Yenepoya Ethics Committee-1  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G218||Other secondary parkinsonism, (2) ICD-10 Condition: G20||Parkinsons disease, (3) ICD-10 Condition: G63||Polyneuropathy in diseases classified elsewhere, (4) ICD-10 Condition: G219||Secondary parkinsonism, unspecified, (5) ICD-10 Condition: G214||Vascular parkinsonism,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  MULTICOMPONENT REHABILITATION.  PHYSIOTHERAPY OPTIMISING PARKINSONS MEDICATIONS(AS PER SENIOR CONSULTANT /TREATING DOCTOR ORDERS) SUPPLIMENTNG VITAMIN B12(1000mcg/day) AND VIT D(2000U/day) 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  60.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1. Patients already diagnosed with parkinsonism and peripheral neuropathy.
2. Age more than or equal to 60 years.
3. Who are able to provide informed consent. 
 
ExclusionCriteria 
Details  1. Patients with major neuro cognitive disorder.
2. Patients with drug induced parkinsonism.
3. Patients of stage Parkinsonism of Hoehn and Yahr classification.
4. Patients who are of multi organ failure and hypoxia.
5. Patients with acute illness and acute infection.
6 Patients of chronic kidney disease on dialysis.
7. Patients who are exposed to neurotoxin or chemotherapy. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1. Reduction in fall risk in elderly.
 
5days
 
 
Secondary Outcome  
Outcome  TimePoints 
2. Improving the balance in elderly.
3. Efficacy of etiology based therapy. 
AT DAY 5 AND AT THE TIME OF DISCHARGE OF THE PATIENT. 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   19/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  


  1. TITLE OF THE RESEARCH TOPIC:  Effect of multicomponent rehabilitation on fall risk reduction in elderly patient hospitalized with parkinsonism and peripheral neuropathy.


This study involves study of geriatric patients/participants with Parkinsonism and its association with peripheral neuropathy and short term in hospital outcomes. Participants with previously diagnosed or newly diagnosed parkinsonism, Vascular Parkinsons or Atypical parkinsonism will be assessed for Peripheral neuropathy and fall risk. Information regarding neuropathy- treatment based on aetiology, physiotherapy details and dopaminergic therapy for parkinsonism will be collected. They are followed up for 5days or until discharge for clinical outcomes - improvement, worsening or status quo will be noted using Neuropathy disability score, steady fall risk score and berg balance scale score and timed up and go test results. Underlying Comorbidities and risk factors will be noted to see whether there is any association with peripheral neuropathy in parkinsonism

 
Close